- Home
- KTB vs LGND Comparison
KTB vs LGND Comparison
Compare KTB & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTB
- LGND
- Stock Information
- Founded
- KTB 2018
- LGND 1987
- Country
- KTB United States
- LGND United States
- Employees
- KTB N/A
- LGND 68
- Industry
- KTB Apparel
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- KTB Consumer Discretionary
- LGND Health Care
- Exchange
- KTB Nasdaq
- LGND Nasdaq
- Market Cap
- KTB 3.6B
- LGND 3.2B
- IPO Year
- KTB N/A
- LGND 1992
- Fundamental
- Price
- KTB $81.93
- LGND $182.61
- Analyst Decision
- KTB Strong Buy
- LGND Strong Buy
- Analyst Count
- KTB 6
- LGND 8
- Target Price
- KTB $91.33
- LGND $144.71
- AVG Volume (30 Days)
- KTB 642.7K
- LGND 139.7K
- Earning Date
- KTB 10-30-2025
- LGND 08-05-2025
- Dividend Yield
- KTB 2.54%
- LGND N/A
- EPS Growth
- KTB 5.71
- LGND N/A
- EPS
- KTB 4.47
- LGND N/A
- Revenue
- KTB $2,650,638,000.00
- LGND $181,488,000.00
- Revenue This Year
- KTB $20.34
- LGND $18.41
- Revenue Next Year
- KTB $11.09
- LGND $18.87
- P/E Ratio
- KTB $18.29
- LGND N/A
- Revenue Growth
- KTB 3.44
- LGND 53.40
- 52 Week Low
- KTB $50.00
- LGND $81.74
- 52 Week High
- KTB $96.80
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- KTB 58.03
- LGND 76.89
- Support Level
- KTB $78.39
- LGND $175.56
- Resistance Level
- KTB $84.32
- LGND $172.45
- Average True Range (ATR)
- KTB 2.18
- LGND 5.19
- MACD
- KTB -0.24
- LGND 0.66
- Stochastic Oscillator
- KTB 60.88
- LGND 92.07
About KTB Kontoor Brands Inc.
Kontoor Brands Inc is a lifestyle apparel company. It is engaged in designing, manufacturing, sourcing, marketing, and distribution of its portfolio of brands, including Wrangler and Lee. It manufactures its products in owned and leased facilities and distributes the products through both brick-and-mortar and e-commerce retailers. The Company has two reportable segments: Wrangler and Lee. It generates the majority of its revenue from the Wrangler segment. The company's geographical segments are the United States and International, of which the majority of its revenue comes from the United States.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.